Daily regulation of glucocerebrosidase activity and impact of fixed-time rotarod training in a mouse model of Gba1-associated Parkinson's disease.
5 affiliations
- 1Department of Diagnostics and Public Health, Section of Pharmacology, University of Verona, Verona, Italy.
- 2Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biology and Genetics, University of Verona, Verona, Italy.
- 3Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Neurology, University of Verona, Verona, Italy.
- 4Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.
- 5Department of Neurosciences, Biomedicine and Movement Sciences, Section of Movement Sciences, University of Verona, Verona, Italy.
Abstract
Introduction
Mutations in the glucocerebrosidase (GBA1) gene are a major genetic risk factor for Parkinson's disease (PD) and result in dysfunctional glucocerebrosidase (GCase), the lysosomal enzyme responsible for cleaving glucosylceramide into glucose and ceramide. The pathogenic L444P variant disrupts the enzyme structure and activity, leading to lysosomal accumulation of glucosylceramide and ultimately impairing the clearance of monomeric α-synuclein (α-syn). Given the functional crosstalk among lysosomal homeostasis, the molecular circadian clock, and physical activity, we investigated whether GCase activity exhibits daily rhythmicity, and can be modulated by daily, fixed-time rotarod activity in healthy and Gba1-mutant mice.Methods
C57BL/6J healthy controls and Gba1-mutant PD model mice were housed under a 12 h light/dark cycle, and blood samples were collected at four Zeitgeber times (ZT2, ZT8, ZT14, and ZT20), with and without daily, fixed-time rotarod training. A fluorometric assay was performed on plasma samples to investigate the daily pattern of GCase activity.Results
Our results showed that rotarod performance was influenced by genotype-dependent vulnerabilities and by daily, fixed-time physical activity, with overall better performance during the dark-phase training. The fluorometric assay revealed that GCase activity shows a ZT-dependent daily pattern in healthy mice, whereas this pattern was disrupted in Gba1-mutant PD models and partially rescued by timed physical activity.Discussion
Overall, both the time of day and daily fixed-time physical activity influenced GCase regulation. Our findings reveal a functional interplay between daily biological timing and lysosomal enzyme regulation, suggesting that optimizing drug dosing and timing of administration may improve the efficacy of GCase-targeted treatments.
Related
- Prism[5]arene Iminosugar Bioconjugates Are Potent Multivalent Inhibitors and Mutation Specific Pharmacological Chaperones of Glucocerebrosidase (GCase) Activity.
- GALC variants affect Glucocerebrosidase to Galactosylceramidase activity ratio
- Unsupervised electrophysiological localization of dorsolateral-associated STN activity using an attention-based contrastive VAE for optimal deep brain stimulation electrode placement in Parkinson’s disease
- Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson’s Disease
- Effects of dual-task training on health-related quality of life and cognitive function in people with Parkinson’s disease: a systematic review and meta-analysis
BibTeX
@article{bertasini2026daily,
title = {{Daily regulation of glucocerebrosidase activity and impact of fixed-time rotarod training in a mouse model of Gba1-associated Parkinson's disease.}},
author = {Chiara Bertasini and Shima Tavakolian Haghighi and Maria Giusy Bruno and Fabio Paio and Carlo Alberto Artusi and Matteo Brunelli and Federico Schena and Massimo Venturelli and Ugo Moretti and Maria Grazia Romanelli and Giovanna Paolone},
journal = {Frontiers in cellular neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fncel.2026.1924016},
url = {https://europepmc.org/article/MED/42903149},
note = {CC BY},
}
RIS
TY - JOUR
TI - Daily regulation of glucocerebrosidase activity and impact of fixed-time rotarod training in a mouse model of Gba1-associated Parkinson's disease.
AU - Chiara Bertasini
AU - Shima Tavakolian Haghighi
AU - Maria Giusy Bruno
AU - Fabio Paio
AU - Carlo Alberto Artusi
AU - Matteo Brunelli
AU - Federico Schena
AU - Massimo Venturelli
AU - Ugo Moretti
AU - Maria Grazia Romanelli
AU - Giovanna Paolone
PY - 2026
DA - 2026/10/06
JO - Frontiers in cellular neuroscience
DO - 10.3389/fncel.2026.1924016
UR - https://europepmc.org/article/MED/42903149
AB - Introduction Mutations in the glucocerebrosidase (GBA1) gene are a major genetic risk factor for Parkinson's disease (PD) and result in dysfunctional glucocerebrosidase (GCase), the lysosomal enzyme responsible for cleaving glucosylceramide into glucose and ceramide. The pathogenic L444P variant disrupts the enzyme structure and activity, leading to lysosomal accumulation of glucosylceramide and ultimately impairing the clearance of monomeric α-synuclein (α-syn). Given the functional crosstalk among lysosomal homeostasis, the molecular circadian clock, and physical activity, we investigated whether GCase activity exhibits daily rhythmicity, and can be modulated by daily, fixed-time rotarod activity in healthy and Gba1-mutant mice.Methods C57BL/6J healthy controls and Gba1-mutant PD model mice were housed under a 12 h light/dark cycle, and blood samples were collected at four Zeitgeber times (ZT2, ZT8, ZT14, and ZT20), with and without daily, fixed-time rotarod training. A fluorometric assay was performed on plasma samples to investigate the daily pattern of GCase activity.Results Our results showed that rotarod performance was influenced by genotype-dependent vulnerabilities and by daily, fixed-time physical activity, with overall better performance during the dark-phase training. The fluorometric assay revealed that GCase activity shows a ZT-dependent daily pattern in healthy mice, whereas this pattern was disrupted in Gba1-mutant PD models and partially rescued by timed physical activity.Discussion Overall, both the time of day and daily fixed-time physical activity influenced GCase regulation. Our findings reveal a functional interplay between daily biological timing and lysosomal enzyme regulation, suggesting that optimizing drug dosing and timing of administration may improve the efficacy of GCase-targeted treatments.
SN - 1662-5102
ER -